文献速递腹部外周血管胸部CT

分次团注单次采集双期腹盆部CT血管成像用于肺移植候选者评估:图像质量与资源利用

Split-Bolus, Single-Acquisition, Dual-Phase Abdominopelvic CT Angiography for the Evaluation of Lung Transplant Candidates: Image Quality and Resource Utilization.
PubMed 文献 · AJR Am J Roentgenol · 2020-10-14

回顾性比较50例双期增强腹盆部CTA与50例单期增强CTA的肺移植候选者,双期组血管强化与单期组无显著差异(334.2±26.5 HU vs 340.0±21.6 HU,p=0.23),但肝实质和肾皮质强化更高(p<0.01),额外影像检查仅6项 vs 44项,每例总费用降低30.6%(p<0.0001)。

要点

  • 双期增强CTA一次注射分次团注即可同时评估血管与腹盆部实质器官,血管强化程度与单期CTA无显著差异。
  • 双期增强CTA肝实质强化125.8±30.5 HU、肾皮质260.3±62.2 HU,均高于单期CTA(60.4±6.9 HU、133.4±38.6 HU)。
  • 双期组仅需6项额外影像检查,单期组需44项,每例总费用降低30.6%。

关键影像表现/征象

  • 沿腹主动脉至右股动脉评估血管强化,双期增强CTA为334.2±26.5 HU(变异系数8.3%),单期增强CTA为340.0±21.6 HU(变异系数6.5%),p=0.23。
  • 肝右叶强化双期增强CTA为125.8±30.5 HU,单期增强CTA为60.4±6.9 HU,p<0.01。
  • 右肾皮质强化双期增强CTA为260.3±62.2 HU,单期增强CTA为133.4±38.6 HU,p<0.01。

临床应用与阅片要点

  • 双期增强CTA可在一次检查中同时显示腹盆部血管和肝、肾实质强化,用于肺移植候选者的联合评估。
  • 双期增强CTA静脉对比剂用量为150 mL,单期增强CTA为75 mL。
  • A组接受6项额外影像检查(其中1项为CT结肠成像,有效剂量19.0 mSv),每例总费用9840美元;B组接受44项额外影像检查(平均有效剂量12.7±6.5 mSv),每例总费用12846美元,双期增强CTA费用降低30.6%,p<0.0001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to assess the image quality and resource utilization of single-injection, split-bolus, dual-enhancement abdominopelvic CT angiography (hereafter referred to as dual-enhancement CTA) performed for combined vascular and solid organ assessment compared with those of single-injection, single-enhancement abdominopelvic CT angiography (hereafter referred to as single-enhancement CTA) for vascular assessment in combination with additional examinations (CT, MRI, and US) performed to assess for malignancy in lung transplant candidates. MATERIALS AND METHODS. We retrospectively reviewed 100 patients who underwent abdominopelvic CTA examinations before lung transplant. Cohort A (n = 50) underwent dual-enhancement CTA and cohort B (n = 50) underwent single-enhancement CTA. Contrast opacification of the vasculature was assessed along the abdominal aorta through the right femoral artery. Solid organ enhancement was assessed in the right lobe of the liver and the right renal cortex. Measurements of mean radiation dose, contrast exposure, and cost of the studies (in U.S. dollars) were compared. RESULTS. Mean (± SD) vascular enhancement on dual-enhancement CTA and single-enhancement CTA was 334.2 ± 26.5 HU (coefficient of variation, 8.3%) and 340.0 ± 21.6 HU (coefficient of variation, 6.5%) (p = 0.23), respectively. For dual-enhancement CTA and single-enhancement CTA, mean liver enhancement was 125.8 ± 30.5 HU and 60.4 ± 6.9 HU (p < 0.01), respectively, whereas mean renal cortical enhancement was 260.3 ± 62.2 HU and 133.4 ± 38.6 HU (p < 0.01), respectively. The mean IV contrast volume was 150 mL for dual-enhancement CTA and 75 mL for single-enhancement CTA. Cohort A underwent six additional imaging studies (one of which was a CT colonography study with an effective dose of 19.0 mSv) at a total cost of $9840 per patient. Cohort B underwent 44 additional imaging studies (mean effective dose, 12.7 ± 6.5 mSv) at a total cost of $12,846 per patient (resulting in a 30.6% reduction in cost for dual-enhancement CTA studies; p < 0.0001). CONCLUSION. Dual-enhancement abdominopelvic CTA allows combined vascular and abdominopelvic solid organ assessment with improved image quality and a lower cost compared with traditional imaging pathways.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Schwartz FR, Khawaja RDA, Marin D, et al. Split-Bolus, Single-Acquisition, Dual-Phase Abdominopelvic CT Angiography for the Evaluation of Lung Transplant Candidates: Image Quality and Resource Utilization. AJR Am J Roentgenol. 2020. PMID: 33052735. doi:10.2214/AJR.19.22335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。